San Diego, CA, United States of America

Michael Joseph Nicoletti

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Joseph Nicoletti: Innovator in Clinical Trial Technology

Introduction

Michael Joseph Nicoletti is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of clinical trials through his innovative approaches and patented technologies. With a total of two patents to his name, Nicoletti is recognized for his expertise in machine learning applications within clinical research.

Latest Patents

Nicoletti's latest patents focus on intelligent planning, execution, and reporting of clinical trials. These patents disclose machine learning-based methods that incorporate a patient burden index. One aspect of his work involves determining a patient burden index by parsing a clinical trial protocol and providing factor data for multiple patients. The method calculates a patient burden index for each patient based on the parsed protocol and the provided factor data, enhancing the efficiency and effectiveness of clinical trials.

Career Highlights

Throughout his career, Nicoletti has worked with notable companies such as Trials.ai, Inc. and ZS Associates, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in clinical trial methodologies.

Collaborations

Some of Nicoletti's coworkers include Kim Marie Walpole and Joshua Michael Stanley. Their collaboration has likely fostered a creative environment that encourages the development of groundbreaking solutions in clinical research.

Conclusion

Michael Joseph Nicoletti stands out as a key innovator in the realm of clinical trials, with his patented technologies paving the way for more efficient and patient-centered research methodologies. His work continues to influence the future of clinical trial execution and reporting.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…